Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2006 Dec 5;25(8):395–398. doi: 10.1002/clc.4950250809

Tricyclic antidepressants and the brugada syndrome: An example of brugada waves appearing after the administration of desipramine

Vasilis C Babliaros 1, J Willis Hurst 1,
PMCID: PMC6654619  PMID: 12173907

Abstract

Since its initial description in the early 1990s, the Brugada syndrome has become increasingly familiar to active researchers and practicing clinicians. The Brugada wave, a characteristic electrocardiographic abnormality of downsloping ST‐segment elevation in leads V1‐V3 and right bundle‐branch block morphology, has Now been associated with an increased risk of sudden death. Currently, very little is known about the relationship between the Brugada syndrome and tricyclic antidepressants. Accordingly, we report the case of a patient who developed prominent Brugada waves with the administration of increasing doses of desipramine. We believe the mechanism of Brugada wave augmentation or production secondary to tricyclic antidepressants is consistent with the current model of early repolarization. We also speculate that the increased risk of sudden death that may occur with tricyclic antidepressants could be related to the development of the Brugada syndrome. We advocate the judicious use of tricyclic antidepressants in cardiac and elderly patients, with careful monitoring of the electrocardiogram for the development Brugada waves.

Keywords: Brugada, electrocardiogram, antidepressant, desipramine, tricyclic, sudden death, arrhythmia

Full Text

The Full Text of this article is available as a PDF (160.6 KB).

References

  • 1. Brugada J, Brugada R, Brugada P: Right bundle‐branch block and ST‐segment elevation in leads V1 through V3. A marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998; 97:457–460 [DOI] [PubMed] [Google Scholar]
  • 2. Gussak I, Antzelevitch C, Bjerregaard P, Towbin J, Chaitman B: The Brugada syndrome: Clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol 1999; 33:5–15 [DOI] [PubMed] [Google Scholar]
  • 3. Chen Q: Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998; 392:293–296 [DOI] [PubMed] [Google Scholar]
  • 4. Litovsky SH, Antzelevitch C: Transient outward current prominent in canine ventricular epicardium but Not endocardium. Circ Res 1988; 62:116–126 [DOI] [PubMed] [Google Scholar]
  • 5. Surawicz B: Brugada syndrome: Manifest, concealed, “asymptomatic”, suspected and simulated. J Am Coll Cardiol 2001; 38(3): 775–777 [DOI] [PubMed] [Google Scholar]
  • 6. Miyazaki T, Matamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S: Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996; 27(5): 1061–1070 [DOI] [PubMed] [Google Scholar]
  • 7. Sumiyoshi M, Nakata Y, Hisaoka T, Ogura S, Nakazato Y, Kawai S, Okada R, Yamaguchi H: A case of idiopathic ventricular fibrillation with incomplete right bundle branch block and persistent ST segment elevation. Jpn Heart J 1993; 34:661–666 [DOI] [PubMed] [Google Scholar]
  • 8. Kasanuki H, Ohnishi S, Ohtuka M, Matsuda N, Nirei T, Isogai R, Shoda M, Toyoshima Y, Hosoda S: Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation 1997; 95:2277–2285 [DOI] [PubMed] [Google Scholar]
  • 9. Lukas A, Antzelevitch C: Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia. The antiarrhythmic effects of 4‐aminopyridine. Cardiovasc Res 1996; 32:593–603 [PubMed] [Google Scholar]
  • 10. Roose S, Glassman A, Giardina EGV, Walsh T, Woodring S, Bigger JT: Tricyclic antidepressants in depressed patients with cardiac conduction disease. Arch Gen Psychiatry 1987; 44:273–275 [DOI] [PubMed] [Google Scholar]
  • 11. Glassman A, Bigger JT: Cardiovascular effects of therapeutic doses of tricyclic antidepressants. Arch Gen Psychiatry 1981; 38:815–820 [DOI] [PubMed] [Google Scholar]
  • 12. Coull DC, Crooks J, Dingwall‐Fordyce I, Scott AM, Weir RD: Amitriptylline and cardiac disease: Risk of sudden death identified by monitoring system. Lancet 1970; 2:590–591 [DOI] [PubMed] [Google Scholar]
  • 13. Tada H, Sticherling C, Oral H, Morady F: Brugada syndrome mimicked by tricyclic antidepressant overdose. J Cardiovasc Electrophysiol 2001; 12(2): 275 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES